Infliximab Benefits Patients with Symptoms of Psoriatic Arthritis
By Emma Hitt
NEW ORLEANS, LA -- October 28, 2002 -- The anti-TNF-alpha agent infliximab appears to improve both synovitis and the skin lesions in psoriatic arthritis.
The findings from a new trial were presented October 27 at the American College of Rheumatology (ACR) 66th Annual Scientific Meeting.
Modified-release sildenafil reduces Raynaud's phenomenon attack frequency in limited cutaneous systemic sclerosis
Herrick AL, van den Hoogen F, Gabrielli A, Tamimi N, Reid C, O'Connell D, Vázquez-Abad MD, Denton CP; Arthritis & Rheumatism 63 (3), 775-82 (Mar 2011)
· Pain Management
FDA Approves New Topical Drug for Head Lice
From Medscape Medical News
Authors and Disclosures
INFORMATION FROM INDUSTRY
A Smart choice for bacterial RTIs and a strong position on the formularies Detailed reimbursement information customized to your locality. Learn more.
Can Sebum Reduction Predict Acne Outcome?
From The British Journal of Dermatology
Sebum excretion has generally been accepted as an important factor in the development of acne vulgaris. However, the relationship of sebum excretion and acne outcome has not yet been clearly demonstrated quantitatively